Eversheds Sutherland advises Molecular Connections on its acquisition of Morressier group

With this strategic acquisition, Molecular Connections combines trusted services with product innovation, creating a differentiated model designed to meet the evolving needs of scholarly publishers and support their critical mission in the research ecosystem.

With over two decades of expertise, Molecular Connections is at the forefront of AI-driven innovation in scholarly publishing. The company specializes in developing proprietary machine-learning models, knowledge graphs, and semantic technologies that drive digital transformation in the academic sphere. Morressier provides societies and publishers with workflows for transforming scholarly communications. Driven by the belief that technology can help create a world in which all scientific outputs are traceable and trustworthy, it is headquartered in Berlin and has offices in London and Washington DC.

The transaction involved multiple jurisdictions, including Germany, UK and US, and required expertise across various legal areas such as Corporate/M&A, IP, Public and Employment Law. The complexity of this cross-border deal highlights Eversheds Sutherland's capability to handle intricate international transactions.

The deal was led by Dr Christophe Samson (Partner, Coroprate/ M&A) and Dr Martin Sanftleben (Counsel, Corporate/ M&A). The wider team involved Daniel von Brevern (Partner, Competition); Dr Lars H. Haverkamp, LL.M. (Partner, Tax); Daniel Ehret (Partner, Finance); Vanessa Flato (Senior Associate, Finance); Felix Hoerl (Senior Associate, Employment); Niklas Schilawa (Senior Associate); Matthias Hartmann (Associate, Corporate/M&A), Doris Perlefein (Associate, Corporate/M&A) and Maren Raband (Associate, Finance).